Stopped trading. Last price we have: $103.37 on Mar 3, 2026. Fund positions aren't valued until we confirm what happened.

EXACT SCIENCES CORP
EXAS (EXACT SCIENCES CORP) is held by 3 institutional investors as of Q1 2026. Top institutional shareholders: Van Eck Associates Corp ($2.2M), Wealth Enhancement Advisory Services, LLC ($1.2M), Huntington National Bank ($1,899).
No verdict yet — fewer than 2 funds hold EXAS.
Top Holders
Showing 1-20 of 258
| Insider | Trade | Traded |
|---|---|---|
| Condella Sarah | Vest 60K sh | |
| Barber Michael J | Disp | |
| Clancy Paul J | Disp | |
| Bloomer Aaron | Vest 90K sh | |
| Conroy Kevin T | Vest 119K sh | |
| Doyle James Edward | Disp | |
| Baranick Brian | Vest 33K sh | |
| ORVILLE JACOB A | Vest 53K sh | |
| Trigg Leslie | Disp | |
| Popovits Kimberly J | Disp |
| Filer | Stake | Filed |
|---|---|---|
| The Vanguard Group | 0.0% | |
| Capital World Investors | 0.5% | |
| FMR LLC | 2.9% | |
| Wellington Management Group LLP | 3.0% | |
| BlackRock, Inc. | 4.3% |
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about EXAS
Who owns EXAS?
3 institutional investors held EXAS on March 31, 2026, led by Van Eck Associates Corp ($2.2M), Wealth Enhancement Advisory Services, LLC ($1.2M) and Huntington National Bank ($1,899).
How many hedge funds hold EXAS?
3 institutional investors reported EXAS in their 13F filings for the quarter ended March 31, 2026, $3.4M in all.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer